+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eylea Market by Indication, End User, Distribution Channel, Dosage Frequency - Global Forecast to 2030- Product Image
Eylea Market by Indication, End User, Distribution Channel, Dosage Frequency - Global Forecast to 2030- Product Image
Sale

Eylea Market by Indication, End User, Distribution Channel, Dosage Frequency - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015393
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Amid shifting regulatory landscapes and competitive market dynamics, the Eylea Market stands at the nexus of innovation and operational precision in ophthalmic therapeutics. Senior decision-makers navigating this sector require concise, actionable intelligence to address emerging challenges, evolving stakeholder expectations, and new supply chain realities.

Market Snapshot: Eylea Market Size and Growth Overview

The Eylea Market expanded from USD 7.25 billion in 2024 to USD 7.77 billion in 2025. This upward trend is projected to persist, with the market expected to reach USD 10.96 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.12%. The primary keyword "Eylea Market" summarises robust historical performance and continued growth momentum across diverse regions and therapeutic segments.

Scope & Segmentation: Understanding Eylea’s Strategic Landscape

This report comprehensively examines Eylea’s position within the broader ophthalmic therapeutics field, analyzing multiple dimensions that influence market outcomes.

  • Indication: Age-Related Macular Degeneration, Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Diabetic Macular Edema, Diabetic Retinopathy.
  • End User: Ambulatory Surgical Centers, Hospitals, Ophthalmic Clinics.
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy.
  • Dosage Frequency: As Needed, Bimonthly, Monthly.
  • Region: Americas, Europe, Middle East & Africa, Asia-Pacific.
  • Key Companies: Regeneron Pharmaceuticals, Bayer Aktiengesellschaft, Roche Holding AG, Novartis AG, AbbVie Inc., Bausch Health Companies Inc.
  • Technology Evolution: Integration of artificial intelligence in diagnostic imaging, adoption of sustained-release implants and gene therapies, digital health enablement platforms.

Key Takeaways: Strategic Insights for Decision-Makers

  • Clinical adoption of Eylea is supported by consistent performance across major retinal disease categories, aligning with the demand for reliable anti-VEGF therapies.
  • Advanced diagnostic tools leveraging artificial intelligence are elevating early detection and individualized therapy, leading to improved resource allocation and patient outcomes.
  • Value-based reimbursement continues to shift commercial models, requiring manufacturers to provide comprehensive real-world evidence for formulary approvals and market access.
  • Ophthalmic clinics, hospitals, and ambulatory centers present unique strengths in patient throughput, care integration, and therapeutic adherence—each contributing to distinct adoption rates.
  • Regional market characteristics, from robust North American reimbursement structures to tiered pricing in emerging markets, underscore the need for flexible go-to-market strategies.

Tariff Impact: Navigating the 2025 U.S. Market Shift

Recent U.S. tariff implementations in 2025 have increased operational complexity for manufacturers and distributors. Higher costs for raw material procurement and longer customs processing times have prompted many organizations to localize supply chains where feasible. Success now depends on transparent pricing dialogues, adaptive logistics partnerships, and proactive scenario planning to sustain competitive positioning amid policy shifts.

Methodology & Data Sources

The report synthesizes insights from primary interviews with KOLs, including retina specialists, supply chain leaders, and health economists, paired with analysis of regulatory filings, clinical trial databases, and proprietary surveys. Cross-validation with secondary sources, such as peer-reviewed journals and government publications, further strengthens the reliability of findings.

Why This Report Matters

  • Equip leadership with segment-level clarity and operational recommendations for market entry, pricing, and innovation planning.
  • Support forecasting and scenario analysis by integrating tariff and regulatory developments into supply chain and commercialization strategies.
  • Enable data-driven decision-making with detailed segmentation and coverage of current treatment, distribution, and competitive trends.

Conclusion

This report provides actionable intelligence to help senior leaders anticipate market shifts and optimize strategies in a complex ophthalmic landscape. Combining clinical, regulatory, and operational perspectives, it enables robust planning for ongoing growth and resilience in the Eylea Market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Eylea Market, by Indication
8.1. Introduction
8.2. Age-Related Macular Degeneration
8.3. Branch Retinal Vein Occlusion
8.4. Central Retinal Vein Occlusion
8.5. Diabetic Macular Edema
8.6. Diabetic Retinopathy
9. Eylea Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.4. Ophthalmic Clinics
10. Eylea Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Eylea Market, by Dosage Frequency
11.1. Introduction
11.2. as Needed
11.3. Bimonthly
11.4. Monthly
12. Americas Eylea Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Eylea Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Eylea Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Regeneron Pharmaceuticals, Inc.
15.3.2. Bayer Aktiengesellschaft
15.3.3. Roche Holding AG
15.3.4. Novartis AG
15.3.5. AbbVie Inc.
15.3.6. Bausch Health Companies Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. EYLEA MARKET MULTI-CURRENCY
FIGURE 2. EYLEA MARKET MULTI-LANGUAGE
FIGURE 3. EYLEA MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL EYLEA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL EYLEA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EYLEA MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EYLEA MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EYLEA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EYLEA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EYLEA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES EYLEA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC EYLEA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EYLEA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. EYLEA MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. EYLEA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EYLEA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EYLEA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL EYLEA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL EYLEA MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL EYLEA MARKET SIZE, BY BRANCH RETINAL VEIN OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL EYLEA MARKET SIZE, BY CENTRAL RETINAL VEIN OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL EYLEA MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL EYLEA MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL EYLEA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL EYLEA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL EYLEA MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL EYLEA MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL EYLEA MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL EYLEA MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL EYLEA MARKET SIZE, BY AS NEEDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL EYLEA MARKET SIZE, BY BIMONTHLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL EYLEA MARKET SIZE, BY MONTHLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS EYLEA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES EYLEA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. CANADA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. CANADA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. CANADA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 38. MEXICO EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. MEXICO EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. MEXICO EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA EYLEA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. UNITED KINGDOM EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED KINGDOM EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED KINGDOM EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. UNITED KINGDOM EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 59. GERMANY EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. GERMANY EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. GERMANY EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. GERMANY EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 63. FRANCE EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. FRANCE EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. FRANCE EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. FRANCE EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 67. RUSSIA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. RUSSIA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. RUSSIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. RUSSIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 71. ITALY EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. ITALY EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. ITALY EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. ITALY EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 75. SPAIN EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. SPAIN EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. SPAIN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. SPAIN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 79. UNITED ARAB EMIRATES EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED ARAB EMIRATES EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. UNITED ARAB EMIRATES EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. UNITED ARAB EMIRATES EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. SOUTH AFRICA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. SOUTH AFRICA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 91. DENMARK EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. DENMARK EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. DENMARK EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. DENMARK EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 95. NETHERLANDS EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. NETHERLANDS EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. NETHERLANDS EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. NETHERLANDS EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 99. QATAR EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. QATAR EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. QATAR EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. QATAR EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 103. FINLAND EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. FINLAND EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. FINLAND EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. FINLAND EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 107. SWEDEN EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. SWEDEN EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. SWEDEN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. SWEDEN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. NIGERIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. NIGERIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 115. EGYPT EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. EGYPT EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. EGYPT EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. EGYPT EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 119. TURKEY EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. TURKEY EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. TURKEY EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. TURKEY EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 127. NORWAY EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. NORWAY EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. NORWAY EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. NORWAY EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 131. POLAND EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. POLAND EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. POLAND EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. POLAND EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC EYLEA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 144. CHINA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. CHINA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. CHINA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. CHINA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 148. INDIA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. INDIA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. INDIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. INDIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 152. JAPAN EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 153. JAPAN EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. JAPAN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. JAPAN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 160. SOUTH KOREA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 168. THAILAND EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. THAILAND EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. THAILAND EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. THAILAND EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 176. MALAYSIA EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. MALAYSIA EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. MALAYSIA EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. SINGAPORE EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 184. VIETNAM EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 188. TAIWAN EYLEA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN EYLEA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN EYLEA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN EYLEA MARKET SIZE, BY DOSAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 192. EYLEA MARKET SHARE, BY KEY PLAYER, 2024
TABLE 193. EYLEA MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Eylea market report include:
  • Regeneron Pharmaceuticals, Inc.
  • Bayer Aktiengesellschaft
  • Roche Holding AG
  • Novartis AG
  • AbbVie Inc.
  • Bausch Health Companies Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.96 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

Eylea HD Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Eylea HD Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Eylea Market Report 2025 - Product Image

Eylea Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Aflibercept (Eylea) Biosimilars Pipeline Review - Product Image

Aflibercept (Eylea) Biosimilars Pipeline Review

  • Report
  • Global
From
Anti-vascular Endothelial Growth Factor Therapeutics Market Size, Share & Trends Analysis Report By Product (Eylea, Lucentis, Beovu), By Disease (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Anti-vascular Endothelial Growth Factor Therapeutics Market Size, Share & Trends Analysis Report By Product (Eylea, Lucentis, Beovu), By Disease (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Anti-vascular Endothelial Growth Factor Therapeutics (VEGF) Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Anti-vascular Endothelial Growth Factor Therapeutics (VEGF) Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 130 Pages
  • Global
From

About the Eylea Market

Eylea is a cardiovascular drug used to treat a variety of conditions, including age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. It is a recombinant human monoclonal antibody fragment that works by inhibiting the activity of vascular endothelial growth factor (VEGF). This helps to reduce the growth of abnormal blood vessels in the eye, which can lead to vision loss. Eylea is administered as an intravitreal injection, and is typically given every four to eight weeks. The Eylea market is highly competitive, with a number of companies offering similar products. These companies include Regeneron Pharmaceuticals, Novartis, Allergan, and Bayer. Each company has its own unique approach to the market, with different pricing strategies and product offerings. As such, the market is constantly evolving, with new products and strategies being developed to meet the needs of patients. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.